Table 1. Population characteristics of the Framingham Heart Study population used in the current study.
| CHD cases | Non-CHD controls | P-valuea | |
|---|---|---|---|
| n=221 | n=6200 | ||
| Female, n (%) | 74 (33%) | 3412 (55%) | |
| Age, years | 39±8 | 38±9 | |
| Body mass index, kg/m2 | 26±4 | 26±5 | 0.71 |
| Systolic blood pressure, mmHg | 125±14 | 118±14 | 5.3 × 10−13 |
| Diastolic blood pressure, mmHg | 80±10 | 76±10 | 2.7 × 10−9 |
| Total cholesterol, mmol/dl | 5.3±1.1 | 3.1±0.9 | 2.9 × 10−7 |
| High-density lipoprotein cholesterol, mmol/dl | 1.2±0.3 | 1.4±0.4 | 2.0 × 10−9 |
| Triglyceride, mmol/dl | 1.5±1.3 | 1.2±0.9 | 7.7 × 10−4 |
a
P-values after age- and sex-adjustment.